- 米国企業
- TEVA PHARMACEUTICAL INDUSTRIES LTD
TEVA PHARMACEUTICAL INDUSTRIES LTDTEVA
時価総額
$182.6億
PER
34.7倍
2010年 12月31日 | 2011年 12月31日 | 2012年 12月31日 | 2013年 12月31日 | 2014年 12月31日 | 2015年 12月31日 | 2016年 12月31日 | 2017年 12月31日 | 2018年 12月31日 | 2019年 12月31日 | 2020年 12月31日 | 2021年 12月31日 | 2022年 12月31日 | 2023年 12月31日 | |
Cash and cash equivalents | 1,248 | 1,096 | 2,879 | 1,038 | 2,226 | 6,946 | 988 | 963 | 1,782 | 1,975 | 2,177 | 2,165 | 2,801 | 3,226 |
Accounts Receivable, Net, Current | 5,476 | 6,213 | 5,572 | 5,338 | 5,408 | 5,350 | 7,523 | 7,128 | 5,822 | 5,676 | 4,581 | 4,529 | 3,696 | 3,408 |
Inventories | 3,866 | 5,012 | 5,502 | 5,053 | 4,371 | 3,966 | 4,954 | 4,924 | 4,731 | 4,422 | 4,403 | 3,818 | 3,833 | 4,021 |
Prepaid expenses | - | - | - | - | - | - | - | - | 899 | 870 | 945 | 1,075 | 1,162 | 1,255 |
Other current assets | - | - | - | - | - | - | - | - | 468 | 434 | 710 | 965 | 549 | 504 |
Assets held for sale | - | - | - | - | - | - | - | - | 92 | 87 | 189 | 19 | 10 | 70 |
Total current assets | 12,042 | 14,453 | 16,355 | 13,720 | 14,396 | 18,398 | 16,961 | 15,382 | 13,794 | 13,464 | 13,005 | 12,573 | 12,051 | 12,485 |
Deferred income taxes | - | - | - | - | - | - | - | - | - | - | 695 | 596 | 1,453 | 1,812 |
Other non-current assets | 138 | 142 | 1,338 | 1,696 | 1,569 | 2,616 | 1,235 | 932 | 731 | 591 | 538 | 515 | 441 | 470 |
Property, plant and equipment, net | 4,357 | 5,947 | 6,315 | 6,635 | 6,535 | 6,544 | 8,073 | 7,673 | 6,868 | 6,436 | 6,296 | 5,982 | 5,739 | 5,750 |
Operating lease right-of-use assets | - | - | - | - | - | - | - | - | - | 514 | 559 | 495 | 419 | 397 |
Identifiable intangible assets, net | - | - | - | - | - | - | - | - | 14,005 | 11,232 | 8,923 | 7,466 | 6,270 | 5,387 |
Goodwill | 15,232 | 18,293 | 18,856 | 18,981 | 18,408 | 19,025 | 44,409 | 28,414 | 24,917 | 24,846 | 20,624 | 20,040 | 17,633 | 17,177 |
Total assets | 38,152 | 50,142 | 50,609 | 47,508 | 46,420 | 54,258 | 92,890 | 70,615 | 60,683 | 57,470 | 50,640 | 47,666 | 44,006 | 43,479 |
Debt, Current | 1,432 | 3,749 | 3,006 | 1,804 | 1,761 | 1,585 | 3,276 | 3,646 | 2,216 | 2,345 | 3,188 | 1,426 | 2,109 | 1,672 |
Sales reserves and allowances | - | - | 4,934 | 4,918 | 5,849 | 6,601 | 7,839 | 7,881 | 6,711 | 6,159 | 4,824 | 4,241 | 3,750 | 3,535 |
Accounts payables | - | - | - | - | - | - | - | - | - | - | 1,756 | 1,686 | 1,887 | 2,602 |
Employee-related obligations | - | - | - | - | - | - | - | - | 870 | 693 | 685 | 563 | 566 | 611 |
Accrued expenses | - | - | - | - | - | - | 3,405 | 3,014 | 1,868 | 1,869 | 1,780 | 2,208 | 2,151 | 2,771 |
Other current liabilities | 995 | 1,396 | 1,572 | 1,926 | 1,508 | 1,225 | 867 | 724 | 804 | 889 | 933 | 903 | 1,005 | 1,056 |
Total current liabilities | 9,694 | 13,847 | 12,888 | 11,965 | 12,289 | 13,005 | 18,519 | 17,921 | 14,322 | 13,674 | 13,164 | 11,027 | 11,469 | 12,247 |
Deferred income taxes | - | - | - | - | - | - | - | - | - | - | 964 | 784 | 548 | 606 |
Other Liabilities, Noncurrent | 777 | 1,106 | 1,293 | 1,273 | 1,109 | 1,195 | 1,639 | 1,843 | 1,727 | 2,640 | 2,240 | 2,578 | 3,847 | 4,019 |
Senior notes and loans | 4,097 | 10,236 | 11,712 | 10,387 | 8,566 | 8,383 | 32,524 | 28,829 | 26,700 | 24,562 | 22,731 | 21,617 | 19,103 | 18,161 |
Operating lease liabilities | - | - | - | - | - | - | - | - | - | 435 | 479 | 416 | 349 | 320 |
Total long-term liabilities | 6,456 | 13,952 | 14,854 | 12,907 | 10,776 | 11,326 | 39,378 | 33,949 | 30,567 | 28,733 | 26,414 | 25,395 | 23,846 | 23,106 |
Total liabilities | 16,150 | 27,799 | 27,742 | 24,872 | 23,065 | 24,331 | 57,897 | 51,870 | 44,889 | 42,407 | 39,579 | 36,422 | 35,315 | 35,353 |
Common Stock, Value, Issued | 49 | 50 | 50 | 50 | 50 | 52 | 54 | 54 | 56 | 56 | 57 | 57 | 57 | 57 |
Additional paid-in capital | 13,246 | 13,374 | 13,474 | 13,628 | 14,121 | 17,757 | 23,409 | 23,479,000,000 | 27,210 | 27,312 | 27,443 | 27,561 | 27,688 | 27,807 |
Accumulated deficit | 9,325 | 11,284 | 12,346 | 12,535 | 14,436 | 14,851 | 13,607 | -3,803 | -5,958 | -6,956 | -10,946 | -10,529 | -12,882 | -13,534 |
Accumulated other comprehensive loss | 350 | -589 | -17 | -91 | -1,343 | -1,955 | -3,159 | -1,853 | -2,459 | -2,312 | -2,399 | -2,683 | -2,838 | -2,697 |
Treasury shares as of December 31, 2023 and December 31, 2022: 106 million ordinary shares | 1,023 | 1,924 | 3,085 | 3,557 | 3,951 | 4,227 | 4,194 | 4,149 | 4,142 | 4,128 | 4,128 | 4,128 | 4,128 | 4,128 |
Stockholders' equity attributable to Teva shareholders | 22,002 | 22,343 | 22,867 | 22,636 | 23,355 | 29,927 | 34,993 | 18,745 | 15,794 | 15,063 | 11,061 | 11,244 | 8,691 | 8,126 |
Non-controlling interests | 55 | 148 | 99 | 71 | 42 | 158 | 1,656 | 1,386 | 1,087 | 1,091 | 1,035 | 966 | 794 | 620 |
Total equity | 22,002 | 22,343 | 22,867 | 22,636 | 23,355 | 29,927 | 34,993 | 18,745 | 15,794 | 15,063 | 11,061 | 11,244 | 8,691 | 8,126 |
Total liabilities and equity | 38,152 | 50,142 | 50,609 | 47,508 | 46,420 | 54,258 | 92,890 | 70,615 | 60,683 | 57,470 | 50,640 | 47,666 | 44,006 | 43,479 |